Table 2 Characteristics of patients identified with a resectable lesion in the complete proregal cohort including which guideline would have accurately identified these patients being at risk

From: Accuracy of upper endoscopies with random biopsies to identify patients with gastric premalignant lesions who can safely be exempt from surveillance

# Age diagnosis Gender First diagnosis of GPL Guideline recommending surveillance Lesions at end of surveillance High-risk feature(s) OLGIM (most severe) Lesion found in follow-up Therapy
1 78a Male 1996 None Moderate intestinal metaplasia of antrum and angulus None III High-grade dysplasia antrum Endoscopic resection
2 57 Male 2010 None Moderate intestinal metaplasia of antrum and angulus None IV Intestinal-type adenocarcinoma angulus Endoscopic resection
3 64 Female 2009 None Slight intestinal metaplasia of the antrum None III Low-grade dysplasia of the antrum Endoscopic resection
4 77 Male 1996 MAPS-2019
Chronic gastritis of antrum and corpus First degree family with GC, AI gastritis IV High-grade dysplasia of the antrum No therapy
5 46 Male 2008 MAPS-2019
N/A First degree family with GC II Intestinal-type adenocarcinoma antrum Endoscopic resection
6 53 Female 2009 MAPS-2012
N/A First degree family with GC III Diffuse-type gastric cancer Total gastrectomy
7 72a Male 2006 MAPS-2012
N/A None IV Intestinal-type adenocarcinoma
Lesser curvature/angulus
Total gastrectomy
  1. GPL gastric premalignant lesion; MAPS management of precancerous conditions and lesions in the stomach; BSG British society of Gastroenterology guideline; N/A not applicable; GC gastric cancer; AI autoimmune
  2. aPatient is deceased